Everest Medicines Announces Completion of Patient Enrollment in Phase 3 Clinical Trial of Etrasimod in Asia ...Middle East

SHANGHAI, May 16, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today the completion of patient enrollment in a...

Hence then, the article about everest medicines announces completion of patient enrollment in phase 3 clinical trial of etrasimod in asia was published today ( Wednesday 17/05/2023 - 02:53 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Everest Medicines Announces Completion of Patient Enrollment in Phase 3 Clinical Trial of Etrasimod in Asia )

Also on site :

• BTS Dominates YouTube’s Global, U.S. Charts
• ‘America’s Culinary Cup’ Season 1: Who Went Home Tonight? (Night 5 Elimination)
• ‘Like relying on a drug dealer:’ The world’s dependence on oil and gas has exposed a dangerous vulnerability